International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.12782565
Original Research Article
Evaluation of Bone Marrow Aspiration in Pancytopenia
Published
Jan. 23, 2025
Abstract

Background: Pancytopenia is not a disease entity but a triad of findings that may result from various disease processes, primarily or secondarily involving the bone marrow. Bone marrow aspiration plays an important role in identifying the various causes of pancytopenia. Hence the present study was undertaken to evaluate bone marrow findings in pancytopenia cases and causes of pancytopenia on the basis of bone marrow findings. Method: Total 50 patients of aged between 18-70 years presented with pancytopenia in the Department of Pathology, at tertiary care teaching hospital in central India during a period from September 2018 to October 2020 were enrolled and evaluated for physical findings, primary hematological investigation and bone marrow aspirations. Results: Commonest age group affected was 41-50 years (28%) with male predominance (68%). General weakness (90%) was the chief complaint and pallor (96%) was commonest physical finding. Megaloblastic anemia (48%) was the common cause of pancytopenia, followed by dimorphic anemia (18%). Lowest hemoglobin range was 3gms/dl-3.5gms/dl noted in case of nutritional and megaloblastic anemia. Lowest leukocyte count was 570cells/mm3 and noted inmegaloblastic anemia. Lowest platelet count was 10,000cells/mm3 and noted in nutritional anemia. Hypercellular marrow was found in 41(82%) patients and common cause was megaloblastic anemia. Hypocellular marrow was seen in 4(8%) cases and normocellular marrow was seen in 5(10%) cases. Conclusion: Detailed primary hematological investigations along with bone marrow aspiration and biopsy in cytopenic patients is helpful for understanding of the disease process, to diagnose or to rule out the causes of cytopenia and helpful in planning further investigations and management of cytopenic patients.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
2919 Views
71 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved